Local Coverage Determination (LCD)

Vestibular and Audiologic Function Studies

L35007

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35007
Original ICD-9 LCD ID
Not Applicable
LCD Title
Vestibular and Audiologic Function Studies
Proposed LCD in Comment Period
N/A
Source Proposed LCD
N/A
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 10/17/2019
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
N/A
Notice Period End Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determination(s) or payment policy rules and regulations for vestibular and audiology services. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions or scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for vestibular and audiology services and must properly submit only valid claims for them. Please review and understand them and apply the medical necessity provisions in the policy within the context of the manual rules. Relevant CMS manual instructions and policies may be found in the following Internet-Only Manuals (IOMs) published on the CMS Web site:

IOM Citations

  • CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Sections 80.3 Audiology Services and 80.6 Requirements for Ordering and Following Orders for Diagnostic Tests
  • CMS IOM Publication 100-04, Medicare Claims Processing Manual:
    • Chapter 12, Section 30.3 Audiology Services
    • Chapter 13, Section 10 ICD Coding for Diagnostic Tests
  • CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4 Reasonable and Necessary Provision in an LCD

Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1833 (e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim
  • Title XVIII of the Social Security Act, Section 1861 (II)(2) addresses payment to Audiologists
  • Title XVIII of the Social Security Act, Section 1861(II)(3)(B) addresses qualifications of Audiologists
  • Title XVIII of the Social Security Act, Section 1862 (a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury
  • Title XVIII of the Social Security Act, Section 1862 (a)(7). This section excludes routine physical examinations

Federal Register References:

  • Title 42 Code of Federal Regulations (CFR) section 410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Vestibular tests are tests of function. Their purpose is to determine if there is something wrong with the vestibular portion of the inner ear. If dizziness is not caused by the inner ear, it might be caused by the brain, medical disorders such as low blood pressure or psychological problems such as anxiety. Studies have documented that vestibular tests are more accurate than clinical examination in identifying inner ear disorders. Hearing pathway tests (audiometry, Auditory Brainstem Response [ABR], Electrocochleography [ECoG]) can also be used for the same purpose and are frequently combined with vestibular tests.

Diagnostic otologic evaluation services are performed to detect presence or absence of a hearing deficit and to identify the factors responsible for the deficit. The assessment of a deficit involves both physical and physiological measurements for appropriate diagnosis and referral.

Accurate assessment of hearing (audiometry) is vital to the diagnostic evaluation of patients with suspected otologic disorders for the determination of the underlying process, as well as in the planning of rehabilitation of hearing loss. Originally, audiometry was limited to the psychophysical measurement of the sensation of hearing; thus, patient cooperation was essential. However, other tests have been developed over the years that permit more objective assessment of hearing even in infants, small children, malingerers and hysterics.

Most humans hear sounds in the range of 20 to 20,000 Hertz (Hz). Sensitivity varies as a function of frequency, with sounds in the middle frequencies being heard best.

Basic Audiometry: Adequate testing requires an audiometer (device for presenting sounds to the patient at precisely controlled intensity), a controlled acoustic environment that meets American National Standards Institute (ANSI) specifications, a competent audiologist and a cooperative patient. The standard testing battery may vary depending on purpose.

  • Pure Tone Audiometry, Speech Audiometry and Immittance Audiometry

    • Pure Tone Audiogram: This is a graphic plot of the patient’s thresholds of audiometry sensitivity for pure tone (sine wave) stimuli. Threshold hearing levels are indicated for each frequency tested. By convention, normal hearing levels are shown at the top of a graph; a decrease in hearing sensitivity is indicated by larger values of hearing level. Hearing level is plotted on a logarithmic decibel scale. Sounds are tested with presentation by air conduction (earphones) as well as bone conduction (skull vibrator). An air bone gap indicates a conductive component of hearing loss. A decrease in threshold sensitivity by bone conduction reflects a sensory or neural loss.

    • Speech Audiometry: These tests utilize spoken words and sentences rather than pure tones. Tests are designed to assess sensitivity (threshold) or understanding (intelligibility).

      • Threshold – The level at which the patient can correctly repeat 50 percent of test materials: Phoneme-Balanced (PB) words, synthetic sentences, etc.
      • Intelligibility – By convention, the percentage of words or sentences a patient can correctly repeat when presented at suprathreshold levels.
      • These tests provide information about a hearing handicap. The hearing deficit may be worse than indicated by Pure Tone Average (PTA) for the speech frequencies. Useful to determine candidacy for hearing aid.
      • Very poor results that are out of proportion to PTA testing, suggest probable retrocochlear cause of hearing loss.
    • Immittance Audiometry: These hearing tests utilize an electroacoustic immittance bridge. This device is designed to quantify the impedance (resistance to movement) of the conductive mechanism of the ear by bouncing a probe tone off the tympanic membrane and measuring the proportion of reflected sound. Impedance testing can measure either the impedance or admittance (the American Speech-Language-Hearing Association term that encompasses both is “immittance”). Typically, today’s equipment measures admittance. The purpose of the test is to assess middle ear integrity. Maximal reflection of sound occurs when the mechanism is very stiff, while a compliant system transmits more sound and reflects less. There are two principal applications of this device:

      • Tympanometry: A tympanogram is a graphic representation of the relationship of external auditory canal air pressure to impedance; the latter is usually reported in terms of tone of its derivatives, compliance in arbitrary units. Pressure in the external auditory canal is varied from -200 daPa through +200 daPa while monitoring impedance. Impedance is the lowest (maximal compliance) when pressure in the canal equals pressure in the middle ear. Ears can be classified into three basic groups (Type A, Type B and Type C) on the basis of the configuration of the tympanogram.
      • Acoustic Reflex (AR): Contraction of the stapedius muscle occurs with loud sounds, producing a measurable change in compliance.

Diagnostic Audiometry consists of a battery of tests intended to determine the site of lesion in patients with otologic or neurologic disorders. The constellation of tests varies according to the available test battery and provisional diagnosis.

  • Immittance audiometry: See above.
  • PI-PB functions: Speech discrimination is plotted as a function of sound intensity. Normally, discrimination improves with intensity up to a maximal level, then plateaus. In eighth nerve disorders, discrimination often declines dramatically as intensity increases above the level yielding maximum performances.
  • Bekesy Audiometry: This test has a significant historical interest in the development of assessment of hearing; however, today it is used predominantly in industrial and military hearing screening situations. Patients trace their own auditory threshold by means of a self-recording audiometer. Tracings are obtained for pulsed as well as continuous tones. The relationship between the two categories can be categorized into diagnostic patterns.
  • Tone Decay Tests: Abnormal adaptation to a continuous tone is seen in retrocochlear lesions.
  • Stenger Test: Performed to detect malingering of unilateral loss. If sound is presented to both ears, the patient will deny hearing in the ear with the feigned loss. If sound is presented to the “good” ear at a suprathreshold level, simultaneous to a louder sound in the questionable ear, a malingerer will localize the sound to his “bad” ear, and therefore deny hearing anything at all.
  • Evoked ABRs: Scalp electrodes measure electrical activity in response to sound clicks. The response is quite small in relation to other ongoing brain activity, but by presenting a large number of clicks and averaging the responses by computer, unrelated events can be canceled out. This is useful for documenting hearing in uncooperative or unresponsive patients. The disadvantage is that it tests mainly the 1,000–4,000 Hz frequency range of hearing and is a poor indicator of the overall auditory function. An abnormal ABR is seen in eighth nerve or brainstem lesions.
  • ECoG: Electrical activity is measured from the promontory and responses to a large number of clicks are averaged. These will be abnormal in eighth cranial nerve lesions and certain cochlear disorders.

Audiologist’s Services

The practice of the profession of audiology means the application of principles, methods and procedures of measurement, testing, evaluation, consultation, counseling, instruction and rehabilitation related to hearing, its disorders and related communication and impairments for the purpose of non-medical diagnosis, prevention, identification, amelioration or modification of such disorders and conditions in individuals or groups of individuals.

Audiological tests require the skills of an audiologist and shall be furnished by qualified audiologists or by a physician who satisfies the "Training and Competency Requirements" as listed in this LCD.

Please refer to CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80.3 for complete information related to audiologist services.

Individuals Who Provide Audiological Tests: Diagnostic audiological tests that require both the technical and professional components, the skills of an audiologist to perform the test and interpret not only the data output but also the manner of the patient’s response to the test must be personally furnished by an audiologist or a physician. The skills of an audiologist required, when furnishing the ordered diagnostic tests, involve skilled judgment or assessment including but not limited to:

  • Interpretation, comparison or consideration of the anatomical or physiological implications of test results or patient responsiveness to stimuli during the test.
  • Modification of the stimulus based on responses obtained during the test.
  • Choices for subsequent presentations of stimuli or tests in a battery of tests.
  • Tests related to implantation of auditory prosthetic devices, central auditory processing or contralateral masking.
  • Tests designed to identify central auditory processing disorders, tinnitus or non-organic hearing loss.

The technical components of certain audiological diagnostic tests, e.g., vestibular function tests that do not require the skills of an audiologist may be performed by a qualified technician or by an audiologist, physician or NPP acting within his/her scope of practice when the qualifications as outlined in the Training and Competency section of the policy are met. If performed by a technician, the service must be provided under the direct supervision (42 CFR §410.32(3)) of a physician who is responsible for all clinical judgment and for the appropriate provision of the service. The physician or NPP bills the directly supervised service as a diagnostic test.

Note: For additional information regarding services performed in an Independent Diagnostic Testing Facility (IDTF), please refer to Local Coverage Determination (LCD) L35448 Independent Diagnostic Testing Facility (IDTF) and Local Coverage Article A53252 Independent Diagnostic Testing Facility (IDTF).

Covered Indications

  1. Vestibular function tests and diagnostic audiometric tests are covered when testing is for the purpose of determining the appropriate medical or surgical treatment for disorders of auditory, balance and other neural systems.
  2. For conductive hearing loss, hearing should be retested after medical or surgical treatment or observation. For sensorineural hearing loss, the audiologist or physician will recommend when reasonable and necessary repeat testing should be done. Since hearing may change or fluctuate, it is important to detect this as early as possible to prevent further loss and to obtain medical treatment if needed. Billing for any testing assumes that the provider has a reasonable expectation that the patient will require medical or surgical treatment. Repeat testing for age-related hearing loss either as a follow-up or to screen for hearing aids is non-covered.
  3. Pure tone audiometry (threshold); air and bone testing, comprehensive hearing testing and acoustic reflex testing may be performed for patients on continuing (current) long-term (more than 14 days) use of antibiotics known to be ototoxic, such as streptomycin and aminoglycosides.
  4. If a physician refers a beneficiary to an audiologist for evaluation of signs and symptoms associated with hearing loss or ear injury, the audiologist’s diagnostic services are covered, even if the only outcome is the prescription of a hearing aid.
  5. Services by an independent audiologist to beneficiaries in a Part B Skilled Nursing Facility (SNF) stay (beneficiaries who have exhausted their Part A-covered SNF stay) are payable under Part B.
  6. Diagnostic analysis of cochlear or brain stem implant and programming are audiology diagnostic services covered under the “other diagnostic test” benefit. Audiological diagnostic tests before and periodically after implantation of auditory prosthetic devices are covered services.

The professional component caloric vestibular testing, nystagmus testing, Sinusoidal vertical axis rotational testing and evoked potential testing are considered reasonable and necessary when performed in inpatient, outpatient, nursing facilities (when Part A benefits have been exhausted), rehabilitation facilities, hearing and speech centers, independent clinics, and independent diagnostic testing facilities (IDTF).

Technical only services are considered reasonable and necessary in the office setting, clinics, hearing and speech centers, and nursing facilities.

Limitations

The following are considered not reasonable and necessary and therefore will be denied:

  1. Screening evaluation or testing for hearing aid evaluation is specifically excluded. This exclusion does not apply to the evaluation for the auditory osseointegrated device, known as the Bone-Anchored Hearing Aid (BAHA) device.
  2. Services are excluded under Section 1862(a)(7) of the Act when:

    • The diagnostic information required to determine the appropriate medical or surgical treatment is already known to the physician or is not under consideration.
    • The diagnostic services are performed only to determine the need for the appropriate type of hearing aid.

    Note: The above services are excluded from Medicare coverage whether performed by a physician or Non-Physician Practitioner (NPP).

  3. If a beneficiary undergoes diagnostic testing performed by an audiologist without a physician’s referral, these tests are not covered even if the audiologist discovers a pathologic condition.
  4. Services documented as audiological services when furnished through use of computer-administered tests that do not require the skills of an audiologist are not covered.
  5. Audiological services billed as incident to the service of a physician or NPP or as services incident to an audiologist’s services are not covered.
  6. When a qualified physician or NPP orders a specific audiological test using the CPT descriptor for the test, only that test may be provided. Further orders are necessary if the ordered test indicates that other tests are necessary to evaluate, for example, the type or cause of the condition. Orders for specific tests are required for technicians. However, when the qualified physician or NPP orders diagnostic audiological tests by an audiologist without naming specific tests, the audiologist may select the appropriate battery of tests.
  7. It is not considered reasonable and necessary to perform these services in the home.
  8. It is not considered reasonable and necessary to perform the technical components of these services in the inpatient hospital, outpatient hospital, or emergency department setting.


Training and Competency Requirements

Vestibular and audiologic testing reported for Medicare payment must be performed by or directly supervised by persons possessing appropriate knowledge and technical expertise of vestibular and hearing. Therefore, Medicare will allow payment for the following:

  • Physicians who have completed training requirements sufficient to satisfy the relevant ABMS/AOA boards for certification in otolaryngology, neurology, neurologic surgery, and physical medicine and rehabilitation,
  • Audiologists licensed by the state(s) in which they practice and are performing services within their state licensure’s scope of practice and Medicare regulation

For frequency limitations please refer to the Utilization Guidelines section below.

Services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for Medical Necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determination, and all Medicare payment rules.

The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information


Refer to the Local Coverage Article: Billing and Coding: Vestibular and Audiologic Function Studies, A57434, for all coding information.

Documentation Requirements

  1. All documentation must be maintained in the patient's medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The medical record documentation must support the medical necessity of the services as stated in this policy.
  4. The total number of timed minutes must be documented in the medical record.
  5. The “other diagnostic tests” benefit requires an order from a physician or, where allowed by state and local law, by an NPP.
  6. The reason for the test should be documented either on the order, the audiological evaluation report, or in the patient’s medical record. Examples of appropriate reasons include but are not limited to:
    1. Evaluation of suspected change in hearing, tinnitus or balance.
    2. Evaluation of the cause of disorders of hearing, tinnitus or balance.
    3. Determination of the effect of medication, surgery or other treatment
    4. Re-evaluation (follow-up changes in hearing, tinnitus or balance) that may be caused by but are not limited to otosclerosis, atelectatic tympanic membrane, tympanosclerosis, cholesteatoma, resolving middle-ear infection, Meniere’s disease, sudden idiopathic sensorineural hearing loss, autoimmune inner-ear disease, acoustic neuroma, demyelinating diseases, ototoxicity secondary to medications, genetic, vascular and viral conditions.
    5. Screening tests are not payable, but failure of a screening test may be an appropriate reason for diagnostic audiological tests.
  7. The medical record shall identify the name and professional identity of the person who ordered the service and the person who actually performed the service. When the medical record is subject to medical review, it is necessary for the Contractor to determine that the service qualifies as an audiological diagnostic test that requires the skills of an audiologist. A technician performing the technical components of audiological tests must meet the qualifications outlined in the training and competency section of this policy. At a minimum, the qualifications must include the requirements of any applicable state or local laws and successful completion of a curriculum including both classroom training and supervised clinical experience in administration of the audiological service.
  8. If a technician performs the technical component of a service that does not require the skills of an audiologist, the physician supervisor shall provide and document the physician’s professional component of the service including, clinical decision-making and other active participation in the delivery of the service. This participation may not also be billed as evaluation and management or as part of other billed services.


Utilization Guidelines

In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.

When monitoring for all ototoxic medications, it is anticipated that the audiologic testing services may be performed as frequently as once a month during the period in which the beneficiary is receiving the antibiotic.

The following utilization guidelines are based on information from the Coder’s Desk Reference:

  • Medicare will not cover the following procedures more than once during a session (same date of service):

    • Spontaneous Nystagmus Test - Electronystagmography (ENG) electrodes are placed on the patient to measure the difference between the patient’s right and left vestibular functions. Recordings are made to detect spontaneous nystagmus.

    • Positional Nystagmus Test – An ENG recording is made of the rapid eye movements occurring when the patient’s head is placed in a variety of positions, e.g., supine with head extended dorsally, left, right and sitting. This is often done using infrared video recording systems.

      Note: Based on the description of the positional nystagmus test, the allowed amount includes a minimum of four positions. This test should not be billed two times for two positions, or any multiple increments.

    • Optokinetic Nystagmus Test – This test is usually done with a rotating drum of alternating light and dark vertical stripes. The drum is placed in front of the patient who is instructed to stare at the drum without focusing on a stripe. The drum is then rotated in one direction, reversed and rotated in the opposite direction. ENG electrodes are used to record nystagmus.

    • Oscillating Tracking Test – ENG electrodes are placed on the patient who is then asked to follow a swinging object (i.e., a ball) on a string. A recording is made of the patient’s eye while it tracks the motion. The recording is then analyzed for smoothness.

    • Sinusoidal Rotational Test – This test is done by seating the patient in a rotating chair and bending his head forward thirty degrees. ENG electrodes are placed on the patient to measure nystagmus while the chair is rotated. The patient’s eyes remain closed during the procedure. A recording is made and studied to determine if there is an abnormal labyrinthine response on one side or the other.
  • Re-evaluation is appropriate at a schedule dictated by the ordering physician when the information provided by the diagnostic test is required to determine changes in hearing, to evaluate the appropriate medical or surgical treatment or to evaluate the results of treatment.
  • Medicare allows payment for two of the following services per patient per year:
    • spontaneous nystagmus test
    • positional nystagmus test
    • optokinetic nystagmus test
    • oscillating tracking test
    • sinusoidal rotational testing 
Sources of Information


Contractor is not responsible for the continued viability of websites listed.

Novitas Solutions, Inc. – JH Local Coverage Determination (LCD) Consolidation

Original JH ICD-9 source LCD L32767, Vestibular Audiologic Function Studies

Other Contractor Policies

Contractor Medical Directors

Bibliography


Cisplatin. In: DrugPoint® Summary.[database on the Internet]. Micromedex®2.0. June 2013.

Fife TD, Tusa RJ, Furman JM, et al. “Assessment: Vestibular Testing techniques in Adults and Children: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology,” Neurology 2000; 55(10): 1431–1441.

Isaacson IE and Vora NM, “Differential Diagnosis and Treatment of Hearing Loss,” American Family Physician 2003; 68(6): 1125–1132.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers, Version 2.2013. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
10/17/2019 R12

LCD revised and published on 10/17/2019. Consistent with CMS Change Request 10901, the entire coding section has been removed from the LCD and placed into the related Billing and Coding Article, A57434. All CPT codes and coding/billing  information within the text of the LCD has been placed in the related Billing and Coding Article. The citations in the IOM and Social Security references have been revised to add section titles and to reorganize citations. Language in the policy that is contained in the CMS manuals has been removed and replaced with the appropriate citation. There has been no change in coverage with this revision.

  • Other (CMS Change Request 10901)
04/25/2019 R11

LCD revised and published on 04/25/2019 in response to CMS Change Request (CR) 10901 to add CMS IOM Publication 100-08, Chapter 13 to the IOM Reference section and to remove the reference and language from the body of the LCD. CMS IOM reference for Publication 100-09 pertains to coding therefore it has been removed from the LCD. LCD standard format changes made to Documentation Requirements. The references have been moved to the Bibliography. There has been no change in coverage with this revision.

  • Other (Changes in response to CMS change request)
12/14/2017 R10

LCD revised and published on 12/14/2017 to correct a statement in the “Coverage Guidance” section by removing “tympanometry (92567)” from the example of technical components as this code has no technical component. Reformatted the "Covered Indications" and “Limitations” sections by replacing bullets with numbers with no change to content. Removed the “Training and Competency Requirement” pertaining to Independent Diagnostic Testing Facility (IDTF) from this LCD and added reference to and hyperlinks for LCD L35448 IDTF and Article A53252 IDTF. Reformatted the CPT Group 1 Codes into separate groups to align with their respective ICD-10 code groups.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Inquiry;
    Other - Clarification)
01/01/2017 R9 LCD revised and published on 04/13/2017 effective for dates of service on and after 01/01/2017 to reflect the first quarter 2017 CPT/HCPCS code updates. For the following CPT code either the short description and/or the long description was changed. Depending on which description is used in this LCD, there may not be any change in how the code displays in the document: 92602.
  • Revisions Due To CPT/HCPCS Code Changes
10/01/2016 R8 LCD revised and published on 09/29/2016 effective for dates of service on and after 10/01/2016 to reflect the ICD-10 Annual Code Updates. The following ICD-10 code(s) have been added to the ICD-10 diagnosis code list for Groups 1,2,3,4,5,7,8,10,11,12: H90.A11, H90.A12, H90.A21, H90.A22, H90.A31 and H90.A32.
  • Revisions Due To ICD-10-CM Code Changes
01/01/2016 R7 LCD revised and published on 06/09/2016 to add CPT codes 92537 and 92538 per CPT/HCPCS update to replace CPT code 92543 effective for dates of service on or after 01/01/2016. CPT codes 92537 and 92538 added to the CPT code listing and to Group 1 codes.
  • Revisions Due To CPT/HCPCS Code Changes
01/01/2016 R6 LCD revised and published on 04/14/2016 to add ICD-10 code G36.1 to Group 11 effective for dates of services on or after 10/01/2015 and to add ICD-10 code R42 to Group 1 effective for dates of service on or after 01/01/2016.
  • Reconsideration Request
01/01/2016 R5 LCD revised and published on 02/11/2016 effective for dates of service on and after 10/01/2015 to add the following ICD-10 diagnosis codes: H81.09, H81.10, H81.20, H81.319, H81.399, H81.49, H81.8X9, H81.90, H83.09, H83.19, H83.2X9, H83.90, H90.0, H90.11, H90.12, H90.2, H90.6, H90.71, H90.72, H90.8, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.21, H91.22, H91.23, H91.8X1-H91.8X9, H91.90-H91.93 to Group 1; H81.09, H81.10, H81.20, H81.319, H81.399, H81.49, H81.8X9, H81.90, H82.9, H83.09, H83.19, H83.2X9, H83.3X9, H83.8X9, H83.90, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19, H93.249 to Group 2; H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93 to Group 3; H81.09, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93 to Group 4; H81.09, H81.10, H81.20, H81.319, H81.399, H81.49, H81.8X9, H81.90, H82.9, H83.09, H83.19, H83.3X9, H83.8X9, H83.90, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19, H93.249 to Group 5; F44.9 to Group 6; H81.09, H81.10, H81.20, H81.319, H81.399, H81.49, H81.8X9, H81.90, H82.9, H83.09, H83.19, H83.2X9, H83.3X9, H83.8X9, H83.90, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19 to Group 7; H81.09, H81.10, H81.20, H81.319, H81.399, H81.49, H81.90-H81.93, H83.09, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19, H93.90 to Group 8; H81.09, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19 to Group 10; C71.6, D33.1, D43.1, G23.0, G23.1, G23.2, G23.9, G25.70, G36.8, G37.2, G37.4, G37.9, G90.3, H46.00, H46.10, H46.9, H81.09, H81.49, H83.3X9, H90.0, H90.11, H90.12, H90.2, H90.5, H90.8, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.3, H91.8X1-H91.8X9, H91.90-H91.93, H93.011, H93.012, H93.013, H93.019, H93.091, H93.092, H93.093, H93.099, H93.19, H93.211, H93.212, H93.213, H93.219, H93.221, H93.222, H93.223, H93.229, H93.231, H93.232, H93.233, H93.239, H93.241, H93.242, H93.243, H93.249, H93.25, H93.291, H93.292, H93.293, H93.299, H93.3X9, H94.00, R25.9, Z01.12, Z01.818, Z45.321 to Group 11; H83.3X9, H90.0, H90.11, H90.12, H90.2, H91.01, H91.02, H91.03, H91.09, H91.10, H91.11, H91.12, H91.13, H91.20, H91.8X1-H91.8X9, H91.90-H91.93, H93.19 to Group 12.
  • Reconsideration Request
01/01/2016 R4 LCD revised and published on 01/28/2016 effective for dates of service on and after 01/01/2016 to reflect the annual CPT/HCPCS code updates. CPT/HCPCS code 92543 has been deleted and therefore removed from the LCD.
  • Revisions Due To CPT/HCPCS Code Changes
10/01/2015 R3 LCD revised and published on 09/11/2015 to remove the following unspecified ICD-10 codes from group 11: G25.70, G25.9, G37.9, H46.9, H90.5, H90.8, H93.3X9, H94.00, R25.9. The unspecified codes were removed since there are other specific codes listed in the policy.
  • Other (Remove listed unspecified ICD-10 codes from group 11.)
10/01/2015 R2 LCD revised and published on 06/25/2015.
  • Creation of Uniform LCDs With Other MAC Jurisdiction
10/01/2015 R1 LCD revised and published on 08/14/2014 to add ICD-10 diagnosis code Z51.11 effective for dates of service 10/01/2014 and after to group 2 as a covered diagnosis.
  • Reconsideration Request
N/A

Associated Documents

Attachments
N/A
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
10/11/2019 10/17/2019 - N/A Currently in Effect You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer